Importantly, CCR1 knockdown reversed the tumor-promoting effects of CCL15, providing strong evidence that CCL15 exerts its oncogenic role in ESCC primarily through CCR1 activation. Here, CCL15 is linked to esophageal squamous cell carcinoma.